Nrf2 is a Critical Mediator of CD4 T Cell-Induced Acute Graft-Versus-Host Disease

被引：0

作者：

Tsai, Jennifer J. ^{[1
]}

Velardi, Enrico ^{[1
]}

Shono, Yusuke ^{[1
,2
]}

Argyropoulos, Kimon ^{[3
]}

Smith, Odette M. ^{[1
]}

Lazrak, Amina ^{[1
]}

Liu, Chen ^{[4
,5
]}

Murphy, George F. ^{[6
,7
]}

Fu, Ya-Yuan ^{[8
]}

Hanash, Alan M. ^{[9
]}

Jenq, Robert R. ^{[10
]}

Dudakov, Jarrod A. ^{[2
,11
,12
]}

van den Brink, Marcel R. M. ^{[10
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, Dept Immunol, Sloan Kettering Inst, New York, NY 10021 USA

[2] Mem Sloan Kettering Canc Ctr, Dept Immunol, New York, NY 10021 USA

[3] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

[4] Rutgers New Jersey Med Sch, Pathol & Lab Med, Newark, NJ USA

[5] Rutgers Robert Wood Johnson Med Sch, Newark, NJ USA

[6] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA

[7] Harvard Med Sch, Dept Pathol, Boston, MA USA

[8] Mem Sloan Kettering Canc Ctr, Med, 1275 York Ave, New York, NY 10021 USA

[9] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA

[10] Mem Sloan Kettering Canc Ctr, Dept Med, Adult Bone Marrow Transplant, 1275 York Ave, New York, NY 10021 USA

[11] Fred Hutchinson Canc Res Ctr, Program Immunol, 1124 Columbia St, Seattle, WA 98104 USA

[12] Fred Hutchinson Canc Res Ctr, Immunotherapy Integrated Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA

来源：

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2018年 / 24卷 / 03期

关键词：

D O I：

10.1016/j.bbmt.2017.12.126

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

229

引用

页码：S175 / S176

页数：2

共 50 条

[21] POLARIZED TYPE-2 ALLOREACTIVE CD4(+) AND CD8(+) DONOR T-CELLS FAIL TO INDUCE EXPERIMENTAL ACUTE GRAFT-VERSUS-HOST DISEASE
KRENGER, W
SNYDER, KM
BYON, JCH
FALZARANO, G
FERRARA, JLM
JOURNAL OF IMMUNOLOGY, 1995, 155 (02): : 585 - 593
[22] Memory CD4 T cells induce graft versus host disease.
Dutt, S
Tseng, D
Ermann, J
Liu, YP
George, TI
Fathman, CG
Strober, S
BLOOD, 2005, 106 (11) : 380A - 380A
[23] DIFFERENTIAL REGULATION OF CD43 GLYCOFORMS ON CD4(+) AND CD8(+) T-LYMPHOCYTES IN GRAFT-VERSUS-HOST DISEASE
ELLIES, LG
JONES, AT
WILLIAMS, MJ
ZILTENER, HJ
GLYCOBIOLOGY, 1994, 4 (06) : 885 - 893
[24] Pre-transplant donor CD4− invariant NKT cell expansion capacity predicts the occurrence of acute graft-versus-host disease
M-T Rubio
M Bouillié
N Bouazza
T Coman
H Trebeden-Nègre
A Gomez
F Suarez
D Sibon
A Brignier
E Paubelle
S Nguyen-Khoc
M Cavazzana
O Lantz
M Mohty
S Urien
O Hermine
Leukemia, 2017, 31 : 903 - 912
[25] Immunodominant CD4(+) T cell receptor V beta repertoires involved in graft-versus-host disease responses to minor histocompatibility antigens
Berger, MA
Korngold, R
JOURNAL OF IMMUNOLOGY, 1997, 159 (01): : 77 - 85
[26] Role of CD28 in acute graft-versus-host disease
Yu, XZ
Martin, PJ
Anasetti, C
BLOOD, 1998, 92 (08) : 2963 - 2970
[27] Identification of a Coordinated CD8 and CD4 T Cell Response Directed Against Mismatched HLA Class I Causing Severe Acute Graft-versus-Host Disease
Amir, Avital L.
Hagedoorn, Renate S.
van Luxemburg-Heijs, Simone A. P.
Marijt, Erik W. A.
Kruisselbrink, Alwine B.
Falkenburg, J. H. Frederik
Heemskerk, Mirjam H. M.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : 210 - 219
[28] MUROMONAB-CD3 IN ACUTE GRAFT-VERSUS-HOST DISEASE
MILLER, ML
SMITH, GH
DRUG INTELLIGENCE & CLINICAL PHARMACY, 1988, 22 (03): : 236 - 237
[29] Selective CD4+ T-cell depletion does not prevent graft-versus-host disease
Nagler, A
Condiotti, R
Nabet, C
Naparstek, E
Or, R
Samuel, S
Slavin, S
TRANSPLANTATION, 1998, 66 (01) : 138 - 141
[30] CCR6 regulates CD4+ T-cell-mediated acute graft-versus-host disease responses
Varona, R
Cadenas, V
Gómez, L
Martínez, AC
Márquez, G
BLOOD, 2005, 106 (01) : 18 - 26

← 1 2 3 4 5 →